235 related articles for article (PubMed ID: 33742141)
1. Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors.
Agaimy A; Michal M; Stoehr R; Ferrazzi F; Fabian P; Michal M; Franchi A; Haller F; Folpe AL; Kösemehmetoğlu K
Mod Pathol; 2021 Aug; 34(8):1507-1520. PubMed ID: 33742141
[TBL] [Abstract][Full Text] [Related]
2. Xanthogranulomatous epithelial tumors and keratin-positive giant cell-rich soft tissue tumors: two aspects of a single entity with frequent HMGA2-NCOR2 fusions.
Dehner CA; Baker JC; Bell R; Dickson BC; Schmidt RE; Demicco EG; Chrisinger JSA
Mod Pathol; 2022 Nov; 35(11):1656-1666. PubMed ID: 35690644
[TBL] [Abstract][Full Text] [Related]
3. Giant Cell Tumors With HMGA2::NCOR2 Fusion : Clinicopathologic, Molecular, and Epigenetic Study of a Distinct Entity.
Perret R; Malaka Z; Velasco V; Llamas-Gutierrez F; Ropars M; Linck PA; Hostein I; Azmani R; Valo I; Galmiche L; Moreau A; de Pinieux G; Michot A; Bochaton D; Coindre JM; Le Loarer F
Am J Surg Pathol; 2023 Jul; 47(7):801-811. PubMed ID: 37170907
[TBL] [Abstract][Full Text] [Related]
4. Keratin-positive giant cell-rich tumors of soft tissue with HMGA2::NCOR2 fusions.
Weigelt MA; Azzato EM; Habermehl GK; Billings SD; Ko JS; Fritchie KJ
J Cutan Pathol; 2023 Nov; 50(11):977-982. PubMed ID: 37496152
[TBL] [Abstract][Full Text] [Related]
5. Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (
Panagopoulos I; Andersen K; Gorunova L; Lund-Iversen M; Lobmaier I; Heim S
Cancer Genomics Proteomics; 2022; 19(2):163-177. PubMed ID: 35181586
[TBL] [Abstract][Full Text] [Related]
6. Xanthogranulomatous Epithelial Tumors and Keratin-Positive Giant Cell Rich Tumors of Soft Tissue and Bone: Two Sides of the Same Coin.
Folpe AL
Surg Pathol Clin; 2024 Mar; 17(1):57-64. PubMed ID: 38278607
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart.
Mancini I; Righi A; Gambarotti M; Picci P; Dei Tos AP; Billings SD; Simi L; Franchi A
Histopathology; 2017 Sep; 71(3):453-460. PubMed ID: 28477388
[TBL] [Abstract][Full Text] [Related]
8. Keratin-Positive Giant Cell-Rich Tumor of Bone Harboring an
Patton A; Ilaslan H; Armstrong SM; Bakhshwin A; Cheng YW; Minhas F; Fritchie KJ
Int J Surg Pathol; 2024 May; 32(3):556-564. PubMed ID: 37461232
[TBL] [Abstract][Full Text] [Related]
9. Primary giant cell tumor of soft tissues: a study of 22 cases.
Oliveira AM; Dei Tos AP; Fletcher CD; Nascimento AG
Am J Surg Pathol; 2000 Feb; 24(2):248-56. PubMed ID: 10680893
[TBL] [Abstract][Full Text] [Related]
10. Giant cell tumors of soft tissue: a clinicopathologic study of 18 benign and malignant tumors.
O'Connell JX; Wehrli BM; Nielsen GP; Rosenberg AE
Am J Surg Pathol; 2000 Mar; 24(3):386-95. PubMed ID: 10716152
[TBL] [Abstract][Full Text] [Related]
11. Giant cell-rich tumour with keratin expression and HMGA2::NCOR2 fusion presenting at a rare location, on the scalp of a 29-year-old male.
Wilsher MJ; Venus M; Fisher C
Pathology; 2024 Jun; 56(4):609-612. PubMed ID: 38341304
[No Abstract] [Full Text] [Related]
12. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
Fanburg-Smith JC; Smith JD; Flemming DJ
Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
[TBL] [Abstract][Full Text] [Related]
13. Primary giant cell tumor of soft tissue of the groin - a case of 46 years duration.
Boneschi V; Parafioriti A; Armiraglio E; Gaiani F; Brambilla L
J Cutan Pathol; 2009 Oct; 36 Suppl 1():20-4. PubMed ID: 19222697
[TBL] [Abstract][Full Text] [Related]
14. GAB1::ABL1 fusions define a distinctive soft tissue neoplasm, with variable perineurial differentiation, and a predilection for children and young adults.
Agaimy A; Perret R; Demicco EG; Gross J; Liu YJ; Azmani R; Engelmann C; Schubart C; Seppet J; Stoehr R; Le Loarer F; Dickson BC
Genes Chromosomes Cancer; 2023 Aug; 62(8):449-459. PubMed ID: 36744864
[TBL] [Abstract][Full Text] [Related]
15. GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions.
Agaram NP; Zhang L; Sung YS; Singer S; Stevens T; Prieto-Granada CN; Bishop JA; Wood BA; Swanson D; Dickson BC; Antonescu CR
Mod Pathol; 2019 Nov; 32(11):1617-1626. PubMed ID: 31189998
[TBL] [Abstract][Full Text] [Related]
16. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
[TBL] [Abstract][Full Text] [Related]
17. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2011 Feb; 35(2):190-201. PubMed ID: 21263239
[TBL] [Abstract][Full Text] [Related]
18. Soft tissue giant cell tumor of low malignant potential: a proposal for the reclassification of malignant giant cell tumor of soft parts.
Folpe AL; Morris RJ; Weiss SW
Mod Pathol; 1999 Sep; 12(9):894-902. PubMed ID: 10496598
[TBL] [Abstract][Full Text] [Related]
19. Extraosseous primary and recurrent giant cell tumors: transforming growth factor-beta1 and -beta2 expression may explain metaplastic bone formation.
Teot LA; O'Keefe RJ; Rosier RN; O'Connell JX; Fox EJ; Hicks DG
Hum Pathol; 1996 Jul; 27(7):625-32. PubMed ID: 8698303
[TBL] [Abstract][Full Text] [Related]
20. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2003 Sep; 27(9):1183-96. PubMed ID: 12960802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
